Expression and Regulation of Breast Cancer Resistance Protein and Multidrug Resistance Associated Protein 2 in BALB/c Mice(Pharmacology)
スポンサーリンク
概要
- 論文の詳細を見る
Microsomal enzyme inducers are known to influence the expression of many transporter proteins and mRNA. In this study, we examined the effects of microsomal enzyme inducers on the mRNA expression of Breast Cancer Resistance Protein (BCRP) and Multidrug Resistance Associated Protein 2 (MRP2) in BALB/c mice. mRNA expression in liver, duodenum, jejunum and ileum was examined in mice, which were treated with microsomal enzyme inducers-aryl hydrocarbon receptor (AhR) ligands 3-methylcholanthrene (3-MC) and pregnane-x-receptor (PXR) ligand pregenolone-16α-carbonitrile (PCN) and compared with control vehicle. The results suggested that the expression level of bcrp mRNA in the ileum was twice that in the liver, duodenum and jejunum using both semi quantitative PCR and Real-time PCR. Mrp2 mRNA was significantly increased by both PCN and 3-MC treatment. In contrast, bcrp mRNA expression was not significantly affected by these inducers. In summary, this study demonstrated that the expression of mrp2 mRNA is regulated by PCN and 3-MC, however, bcrp mRNA expression was not significantly affected by PCN and 3-MC.
- 公益社団法人日本薬学会の論文
- 2006-05-01
著者
-
Han Ying
Department Of Prosthodontics College Of Stomatology The Fourth Military Medical University
-
SUGIYAMA Yuichi
Department of Biopharmaceutics, Graduate School of Pharmaceutical Sciences, The University of Tokyo
-
Han Ying
Department Of Molecular Pharmacokinetics Graduate School Of Pharmaceutical Sciences University Of To
-
Sugiyama Yuichi
Department Of Applied Biological Science Faculty Of Science And Technology Science University Of Tok
-
Sugiyama Yuichi
Department of Molecular Pharmacokinetics, Graduate School of Pharmaceutical Sciences, University of Tokyo
関連論文
- Novel mutations identified in the human multidrug resistance-associated protein 2 (MRP2/ABCC2) gene in a Japanese patient with Dubin-Johnson syndrome
- Association of genetic polymorphisms in SLCO1B3 and ABCC2 with docetaxel-induced leukopenia
- QUANTITATIVE RELATIONSHIP BETWEEN IN VIVO BENZODIAZEPINE RECEPTOR OCCUPANCY AND CEREBRAL METABOLIC CHANGE IN THE MOUSE
- BINDING, INTERNALIZATION AND DEGRADATION OF ATRIAL NATRIURETIC PEPTIDE IN ISOLATED CHOROID PLEXUS
- THE TRANSPORT SYSTEM OF BENZYLPENICILLIN IN THE BLOOD-CEREBROSPINAL FLUID BARRIER
- THE EFFECT OF BASIC DRUGS ON THE HEPATIC TRANSPORT OF CARDIAC GLYCOSIDES IN RATS
- THE TRANSPORT SYSTEM OF CIMETIDINE FROM THE RAT CEREBROSPINAL FLUID : IN VIVO AND IN VITRO STUDIES
- INTERACTION OF OUABAIN AND ROSE BENGAL WITH RAT LIVER PLASMA MEMBRANES
- 22D-11-2 Modifying the pharmacokinetics of the anticancer drug CPT-11, and its active metabolite SN-38, aimed at reducing the biliary excretion of SN-38 and its gastrointestinal toxicity.
- Galactosyldiacylglycerol, a Mammalian DNA Polymerase α-Specific Inhibitor from a Sea Alga, Petalonia bingbamiae
- "S2-4 STRATEGIC PROPOSALS FOR AVOIDING TOXIC INTERACTIONS WITH DRUGS FOR CLINICAL USE DURING DEVELOPMENT AND AFTER MARKETING OF A NEW DRUG : PHARMACOKINETIC CONSIDERATION (Strategy how we can learn drug-drug interaction during the development
- POSSIBLE MECHANISMS FOR THE CHANGES IN MICROCLIMATE-pH IN THE RAT SMALL INTESTINE AND EFFECTS OF PHENOTHIAZINE DERIVATIVES IN VIVO
- Microtensile Bond Strength in the Repair of a Composite Provisional Restorative Material : Effect of Oxygen Inhibition and Bonding Agents
- Expression and Regulation of Breast Cancer Resistance Protein and Multidrug Resistance Associated Protein 2 in BALB/c Mice(Pharmacology)
- Effect of Genetic Polymorphism of OATP-C (SLCO1B1) on Lipid-Lowering Response to HMG-CoA Reductase Inhibitors
- Modulating effect of hydrogen sulfide on gamma-aminobutyric acid B receptor in recurrent febrile seizures in rats
- Pharmacokinetic interaction between pravastatin and olmesartan in relation to SLCO1B1 polymorphism
- Construction of the in vitro transporter experimental systems for prediction of the dexification of drugs in human liver : Utilization of human cryopreserved hepatocytes and double transfectants
- Effects of Serum Albumin and Liver Cytosol on CYP2C9-and CYP3A4-mediated Drug Metabolism
- Lack of Contribution of P-Glycoprotein (P-gp) to Transport via the Mouse Blood-Cerebrospinal Fluid Barrier
- The role of breast cancer resistance protein, Bcrp in the transport of estrone-3-sulfate and dehydroepiandrosterone sulfate across the blood-brain barrier
- Impact of Genetic Polymorphisms of Transporters on the Pharmacokinetic, Pharmacodynamic and Toxicological Properties of Anionic Drugs
- FUTURE PROSPECTS FOR TOXICOKINETICS : PREDICTION OF DRUG DISPOSITION AND ADVERSE EFFECTS IN HUMANS FROM IN VITRO MEASUREMENTS OF DRUG METABOLISM, TRANSPORT AND BINDING
- Analysis of citrulline in rat brain tissue after perfusion with haloperidol by liquid chromatography-mass spectrometry
- Analysis of citrulline in rat brain tissue after perfusion with haloperidol by liquid chromatography-mass spectrometry
- Determination of 1-methyl-1,2,3,4-tetrahydroisoquinoline in mouse brain after treatment with haloperidol by gas chromatography-selected ion monitoring
- Report 3 : FUTURE PROSPECTS FOR TOXICOKINETICS : ITS ABILITY TO PREDICT DRUG ADVERSE EVENTS IN HUMANS (TOXICOKINETICS)
- Association study of genetic polymorphisms of drug transporters, SLCO1B1, SLCO1B3 and ABCC2, in African-Americans, Hispanics and Caucasians and olmesartan exposure